ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

SBIR Priority Score Median Must Match R01s Under House Bill

June 28, 1996

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic

September 25, 1998

FDA Committee to Discuss Policy On Combinations

January 7, 1977